Fc-based half-life extension of human FVIIa--a new player for hemophilia treatment?
Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA; Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA; The University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA. Electronic address: margaritis@email.chop.edu.
Paris
P
Margaritis
D000818:Animals; D015942:Factor VIIa / Q000493:pharmacokinetics*; D006801:Humans; D008297:Male
D015942:Factor VIIa
Coagulation Factor VIIa; Fc fusion; Half-life; Hemophilia